Umberto Tirelli holds an M.D. degree, and he is a specialist in hematology, oncology, and infectious diseases. Tirelli has been the Director of the Department of Medical Oncology, National Cancer Institute, Aviano, Italy, since 2000. He has been a Member of the American Society of Clinical Oncology (ASCO) since 1982, Member of the European Society for Medical Oncology (ESMO) since 1986, Member of the International AIDS Society (IAS) since 1986, Member of the International Immunocompromised Host Society (IHS) since 1994, and Member of Honour of the International Union Against Cancer (UICC) since 1999. He is also a Member of the Editorial Board of the following scientific journals: Cancer and Aging, Cancer Therapy, Chemotherapy Research and Practice, Hematological Oncology, Journal of Cancer Survivorship, and TheScientificWorldJOURNAL. His main areas of research and clinical activities are the following: blood tumors (in particular lymphomas, leukemias and myelomas); tumors of the elderly (in particular lymphomas, breast, lung, stomach and colon-rectum, kidney, bladder and prostate, and head and neck cancers); cancer survivors (treatments assessment and side effect, future prospects in cancer prevention); virus-related tumors (in particular, HIV, hepatitis viruses B and C, human papilloma viruses, Epstein Barr virus; therefore, treatment of cancer of the liver, uterus, and head and neck); urologic tumors (in particular cancer of the prostate, bladder and kidney); head and neck tumors (in particular of the oral cavity, larynx, and esophagus); lung cancers; breast cancer and gastrointestinal tract; new anticancer drugs; chronic fatigue (in particular, chronic fatigue syndrome and other forms of fatigue related to depression, stress, cancer, etc.); HIV (in particular, antiretroviral therapy and treatment of virus-related tumors).
Biography Updated on 29 August 2011